Travel pass: Pros may outweigh cons
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
Capsules and art are not quite two peas in a pod. But that’s precisely what the “Art in a Capsule” global campaign did by getting creative miniatures inside a capsule.
“It was to build awareness around the group and capsules,” says Karan Singh, ACG Managing Director, on the subtle and innovative campaign that was pretty much “in character” for the company.
Despite being the country’s largest capsules producer and second largest in the world, ACG has been shy of the public eye, though it has worked closely with the Indian pharmaceutical industry, offering it high-technology engineering-to-software solutions. “The number of capsules we produce is 20 times the world’s population,” says Karan, whose uncle Ajit and father Jasjit Singh built the company.
A conversation with Karan is peppered with anecdotes, a veritable snapshot from history, even as he is involved with building on the company’s innovative reputation and offering solutions powered by artificial intelligence (AI), machine learning and big data to pharmaceutical companies.
On a softer note on the artful campaign, Karan says one of the winners was from Mumbai, a person with cancer who was moved by the recognition of his art, even as he had to use the prize money to pay for his treatment.
Harking back to the 1960s, he recounts how his uncle Ajit Singh used to take a box full of capsules to customers. It was a time when Cipla promoter-family’s MK and YK Hamied would be in the lab formulating medicines, says Karan. It was when multinational companies were coming to India.
It was a time when an ACG customer expressed difficulties in adding new products as he would have to employ another 1,000 employees, women in this case, to fill capsules with the pharmaceutical ingredients using measuring spoons, he says.
“And that’s where Ajit came back and gave the idea to my father and my father sat with a group of engineers inside the plant and designed the first capsule-filling machine,”says Karan. The engineering division was born thus. The company brought in technology to make blister packs in India and its films business took seed. And as it continued to partner with customers, domestic and foreign, ACG developed technology to help track and trace products, he says.
“Now we are slowly morphing into a contract manufacturing supplier for niche technology, again all related to capsules... We are also looking at technologies like AI, big data, machine learning and creating a software platform for customers that will enable them to optimise their manufacturing. To drive more efficiencies through their plants,” says Karan. This would help lower the cost to produce medicines, making them affordable and of a higher quality, he adds.
Among the niche products ACG has ready for launch is an immunity product that’s awaiting global patents. And there are 55 such products that will be developed in collaboration with customer-companies.
A capsule is a “unique container”, says Karan. “It enables you to not only put a powder but also liquids or pellets or microtablets or a combination of 3-4 components.”
So, while Israeli companies talk of little cameras in a capsule, ACG is looking at technology where capsules can hold microchips that interact with a smart phone, for example, and also working with a university and a biotech company to get biotech products into a capsule. Presently, they are injected into patients.
An early transformation project Karan led in 2004 involved developing vegetarian capsules, made of cellulose from pine tree bark. Usually, it is made from gelatin (animal sources). There are cost and manufacturing challenges, says Karan and yet, manufacturing has grown from one line to two factories today.
Karan is looking to replicate ACG’s India success, abroad, through staying relevant and understanding customer needs. With all its plants digitised, ACG is embarking on its “next big pillar” for growth, says Karan, referring to its software platform for drug companies to leverage the power of AI and machine learning. ACG’s advantage over software companies is its understanding of manufacturing and its processes. Besides, about 190 pharma factories in India already have ACG machines.
Karan admits there’s been interest from investment bankers to get a foothold into ACG. Though family-owned, it is professionally run, he says. And, with his three children now, “succession is in place for the next 50 years,” he says, laughing.
IATA’s mobile application will allow travellers to store and manage certifications for Covid-19 tests or ...
A 2010 Act to regulate the medical sector flounders in implementation, even as healthcare remains ...
The scheme to boost local medtech manufacturing is timely, especially given the raging pandemic. But ...
Do pilots sleep on their job?
Fiscal stimulus, friendly monetary policy and firm commodity prices point towards normalcy, says the MD and ...
Price correction is a good opportunity for long-term investors to take the plunge
Q4 earnings, along with progress in controlling Covid-19 spread, will be in focus
Do keep in mind that premium may go up in case one of the members has a pre-existing condition
In an age of falling female workforce participation, worsened by the Covid-19 pandemic, policy makers and ...
A 25-member team is on a mission to revive Urdu calligraphy
Of an injured baby goat, young men on motorcycles and political tensions
It’s the birthday of Muttiah Muralitharan — the man who took a staggering 800 test wickets. What better way to ...
Monotype’s 2021 type trends report points to a return to hand and the familiar
As ‘ear-points’ between a company and a customer grow, we are witnessing a rise in audio assets
‘Desi Twitter challenger’ Koo on connecting like-minded folks
Coca-Cola has just introduced an oat milk line in the US under its Simply brand. Smart move, say industry ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor